IP Verse

Prevention And Treatment Of Thromboembolic Disorders

Patent No. EP1845961 (titled "Prevention And Treatment Of Thromboembolic Disorders") was filed by Bayer on Jan 19, 2006. The application was issued on Apr 22, 2015.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (15)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KRKAApr 14, 2021HOEFER & PARTNER PATENTANWALTE MBB
ZENTIVA KSMar 19, 2021ELLIS
ABG LAWJan 26, 2016ABG PATENTES
GALENICUM HEALTH SLUJan 22, 2016GALENICUM HEALTH SLU
HEXALJan 22, 2016LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB
KRAUS & WEISERTJan 22, 2016ADAM
STOLMAR MATTHIASJan 22, 2016STOLMAR & PARTNER
ABDI IBRAHIM ILAC SANAYI VE TICARET ANONIM SIRKETIJan 21, 2016-
GENERICS UK TRADING MYLANJan 21, 2016ELEND
POLPHARMAJan 21, 2016ELKINGTON AND FIFE
STADA ARZNEIMITTELJan 21, 2016KERNEBECK
TEVA PHARMACEUTICAL INDUSTRIES LTDJan 21, 2016ELKINGTON AND FIFE
WITTKOPPJan 21, 2016HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
ACTAVIS GROUP PTC EHFJan 6, 2016ELKINGTON AND FIFE
BREUERJul 22, 2015FERRER INTERNACIONAL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1845961

BAYER
Application Number
EP06706291A
Filing Date
Jan 19, 2006
Status
Opposition Rejected
Jun 29, 2022
Publication Date
Apr 22, 2015
External Links
Slate, Register , Google Patents